publication date: Dec. 20, 2010

In this issue: 

Medicare increases payments for oncology infusion and begins a one-year demonstration project that pays oncologists to assess the side effects of chemotherapy.

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

Also Unclear whether HHS Secretary Tommy Thompson will depart as previously planned.

California approves $3 billion program for stem-cell research.

Oklahoma’s new cigarette tax will provide $7 million a year to the University of Oklahoma Cancer Center.

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

Funding opportunities listed.

October issue of Business & Regulatory Report included.

Download (PDF 1.3MB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.